BOT 0.00% 38.0¢ botanix pharmaceuticals ltd

Ann: FDA Letter Requires Patient Instruction Update, page-68

  1. 12,209 Posts.
    lightbulb Created with Sketch. 6222
    Timeframe is mid 2024.. so not a quick in and out fix..

    But in the quantum of the application the jury is out and the Science is positive and approved..

    Botanix will meet with FDA and undertake the minor activities and plans to resubmit the NDA by early
    Q1 CY2024, with a target approval of mid-CY2024
    Last edited by NZ Trader: 26/09/23
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.